Richard Doocey

Allogeneic haematopoietic stem‐cell transplantation for relapsed and refractory aggressive histology non‐Hodgkin lymphoma*

Richard Doocey, Cynthia L. Toze, Joseph M. Connors et al. · British Journal of Haematology · 2005 · 87 citations · Full text

Medicine, Hematology, Oncology +15

Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the <scp>COVID</scp>‐19 pandemic

Pietro R Di Ciaccio, Georgia McCaughan, Judith Trotman et al. · Internal Medicine Journal · 2020 · 43 citations · Full text

Medicine, Infectious Diseases, Oncology +15

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With <i>NPM1</i> and <i>FLT3</i> Mutations

Nigel H. Russell, Charlotte S. Wilhelm-Benartzi, Jad Othman et al. · Journal of Clinical Oncology · 2024 · 41 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study

Stephen Couban, Mahmoud Aljurf, Irwin Walker et al. · Biology of Blood and Marrow Transplantation · 2016 · 26 citations · Full text

Medicine, Hematology, Immunology +14

CD56 ^bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft- <i>versus</i> -host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results

Amina Kariminia, Sabine Ivison, Bernard Ng et al. · Haematologica · 2017 · 22 citations · Full text

Medicine, Hematology, Immunology +15